Proposed Information Collection; Comment Request; Survey: Expenditures Incurred by Recipients of Biomedical Research and Development Awards From the National Institutes of Health (NIH), 21824-21825 [2020-08239]
Download as PDF
21824
Federal Register / Vol. 85, No. 76 / Monday, April 20, 2020 / Notices
Agenda: Friday, May 15, 2020 at 1:00
p.m. (EDT)
I. Roll Call
II. Welcome
III. Project Planning
IV. Other Business
V. Next Meeting
VI. Public Comments
VII. Adjourn
Dated: April 15, 2020.
David Mussatt,
Supervisory Chief, Regional Programs Unit.
[FR Doc. 2020–08278 Filed 4–17–20; 8:45 am]
BILLING CODE P
DEPARTMENT OF COMMERCE
Bureau of Economic Analysis
Proposed Information Collection;
Comment Request; Survey:
Expenditures Incurred by Recipients of
Biomedical Research and
Development Awards From the
National Institutes of Health (NIH)
Bureau of Economic Analysis,
Department of Commerce.
ACTION: Notice.
AGENCY:
The Department of
Commerce, as part of its continuing
effort to reduce paperwork and
respondent burden as required by the
Paperwork Reduction Act of 1995,
invites the general public and other
Federal agencies to comment on
continuing information collections
related to the Expenditures Incurred by
Recipients of Biomedical Research and
Development Awards survey from the
National Institutes of Health (NIH).
DATES: Written comments must be
submitted on or before June 19, 2020.
ADDRESSES: Direct all written comments
to Jennifer A. Bennett, Chief, Training
and Staff Development Section,
Expenditure and Income Division,
Bureau of Economic Analysis, 4600
Silver Hill Road, BE–57, Washington,
DC 20233, or via email at
PRAcomments@doc.gov. All comments
received are part of the public record.
Comments will generally be posted
without change. All Personally
Identifiable Information (for example,
name and address) voluntarily
submitted by the commenter may be
publicly accessible. Do not submit
Confidential Business Information or
otherwise sensitive or protected
information. You may submit
attachments to electronic comments in
Microsoft Word, Excel, or Adobe PDF
file formats.
FOR FURTHER INFORMATION CONTACT:
Requests for additional information or
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:34 Apr 17, 2020
Jkt 250001
copies of the information collection
instrument and instructions should be
directed to Jennifer A. Bennett, Chief,
Training and Staff Development
Section, Expenditure and Income
Division (BE–57), Bureau of Economic
Analysis, U.S. Department of
Commerce, 4600 Silver Hill Rd.
Washington, DC 20233; or via email at
jennifer.bennett@bea.gov.
SUPPLEMENTARY INFORMATION:
I. Abstract
The survey obtains the distribution of
expenditures incurred by recipients of
biomedical research awards from the
National Institutes of Health (NIH) and
will provide information on how the
NIH award amounts are expended
across several major categories. This
information, along with wage and price
data from other published sources, will
be used to generate the Biomedical
Research and Development Price Index
(BRDPI). The Bureau of Economic
Analysis (BEA) develops this index for
NIH under a reimbursable contract. The
BRDPI is an index of prices paid for the
labor, supplies, equipment, and other
inputs required to perform the
biomedical research the NIH supports in
its intramural laboratories and through
its awards to extramural organizations.
The BRDPI is a vital tool for planning
the NIH research budget and analyzing
future NIH programs. A survey of award
recipients is currently the only means
for updating the expenditure category
weights that are used to prepare the
BRDPI.
II. Authority
This survey will be voluntary. The
authority for NIH to collect information
for the BRDPI is provided in 45 CFR
subpart C, Post-Award Requirements,
section 74.21. This sets forth explicit
standards for grantees in establishing
and maintaining financial management
systems and records, and section 74.53
which provides for the retention of such
records as well as NIH access to such
records.
BEA will administer the survey and
analyze the survey results on behalf of
NIH, through an interagency agreement
between the two agencies. The authority
for the NIH to contract with the
Department of Commerce (DOC) to
make this collection is the Economy Act
(31 U.S.C. 1535 and 1536).
The ‘‘Special Studies’’ authority, 15
U.S.C. 1525 (first paragraph), permits
DOC to provide, upon the request of any
person, firm, or public or private
organization (a) special studies on
matters within the authority of the DOC,
including preparing from its records
special compilations, lists, bulletins, or
PO 00000
Frm 00003
Fmt 4703
Sfmt 4703
reports, and (b) furnishing transcripts or
copies of its studies, compilations and
other records. NIH’s support for this
research is consistent with the Agency’s
duties and authority under 42 U.S.C.
282.
The information provided by the
respondents will be held confidential
and be used for exclusively statistical
purposes. This pledge of confidentiality
is made under the Confidential
Information Protection provisions of
title V, subtitle A, Public Law 107–347.
Title V is the Confidential Information
Protection and Statistical Efficiency Act
of 2002 (CIPSEA). Section 512 (on
Limitations on Use and Disclosure of
Data and Information) of the Act,
provides that ‘‘data or information
acquired by an agency under a pledge of
confidentiality and for exclusively
statistical purposes shall be used by
officers, employees, or agents of the
agency exclusively for statistical
purposes. Data or information acquired
by an agency under a pledge of
confidentiality for exclusively statistical
purposes shall not be disclosed by an
agency in identifiable form, for any use
other than an exclusively statistical
purpose, except with the informed
consent of the respondent.’’
Responses will be kept confidential
and will not be disclosed in identifiable
form to anyone, other than employees or
agents of BEA or agents of NIH, without
prior written permission of the person
filing the report. By law, each employee
as well as each agent is subject to a jail
term of up to 5 years, a fine of up to
$250,000, or both for disclosing to the
public any identifiable information that
is reported about a business or
institution.
Section 515 of the Information
Quality Guidelines applies to this
survey. The collection and use of this
information comply with all applicable
information quality guidelines, i.e.,
those of the Office of Management and
Budget, Department of Commerce, and
BEA.
III. Method of Collection
A survey with a cover letter that
includes a brief description of, and
rationale for, the survey will be sent by
email to potential respondents by the
first week of August 2020, 2021, and
2022. A report of the respondent’s
expenditures of the NIH award amounts,
including NIH awards received as a subrecipient from another institution,
following the proposed format for
expenditure categories included with
the survey form, will be requested to be
completed and submitted online no
later than December 8, which in most
years will be approximately 120 days
E:\FR\FM\20APN1.SGM
20APN1
Federal Register / Vol. 85, No. 76 / Monday, April 20, 2020 / Notices
after mailing. Survey respondents will
be selected based on award levels,
which determine the weight of the
respondent in the biomedical research
and development price index. Potential
respondents will include (1) The top
100 organizations in total awards, which
account for about 77 percent of total
awards; (2) 40 additional organizations
that are not primarily in the ‘‘Research
and Development (R&D) contracts’’
category; and (3) 10 additional
organizations that are primarily in the
‘‘R&D contracts’’ category.
IV. Data
OMB Control Number: 0608–0069.
Form Number: None.
Type of Review: Regular submission.
Affected Public: Universities or other
organizations that are NIH award
recipients.
Estimated Number of Respondents:
150.
Estimated Time per Response: 16
hours but may vary among respondents
because of differences in institution
structure, size, and complexity.
Estimated Total Annual Burden
Hours: 2,400 hours.
Estimated Total Annual Cost to
Public: $0.
V. Request for Comments
jbell on DSKJLSW7X2PROD with NOTICES
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the NIH, including
whether the information has practical
utility; (b) the accuracy of the agency’s
estimate of the burden (including hours
and cost) of the proposed collection of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and/or
included in the request for OMB
approval of this information collection;
they also will become a matter of public
record.
Dated: April 14, 2020.
Sheleen Dumas,
Department PRA Clearance Officer, Office of
the Chief Information Officer, Commerce
Department.
[FR Doc. 2020–08239 Filed 4–17–20; 8:45 am]
BILLING CODE 3510–EA–P
VerDate Sep<11>2014
18:34 Apr 17, 2020
Jkt 250001
21825
International Trade Administration
this administrative review in
accordance with section 751 of the
Tariff Act of 1930, as amended (the Act).
[A–475–835]
Scope of the Order
Finished Carbon Steel Flanges From
Italy: Final Results of Antidumping
Duty Administrative Review; 2017–
2018
The products covered by the scope of
the order are steel flanges from Italy. For
a complete description of the scope of
the order, see the Issues and Decision
Memorandum.6
DEPARTMENT OF COMMERCE
Enforcement and Compliance,
International Trade Administration,
Department of Commerce.
SUMMARY: The Department of Commerce
(Commerce) finds that sales of finished
carbon steel flanges (steel flanges) from
Italy were made at less than normal
value during the period of review (POR)
February 8, 2017 through July 31, 2018.
DATES: Applicable April 20, 2020.
FOR FURTHER INFORMATION CONTACT:
Preston N. Cox, AD/CVD Operations,
Office VI, Enforcement and Compliance,
International Trade Administration,
U.S. Department of Commerce, 1401
Constitution Avenue NW, Washington,
DC 20230; telephone: (202) 482–5041.
SUPPLEMENTARY INFORMATION:
AGENCY:
Background
On October 17, 2019, Commerce
published the Preliminary Results of the
2017–2018 antidumping duty
administrative review of steel flanges
from Italy and invited interested parties
to comment.1 This administrative
review covers 27 companies. The
mandatory respondents are Forgital Italy
S.p.A. (Forgital) and ASFO S.p.A.
(ASFO). On November 18, 2019, we
received a timely filed case brief from
Forgital,2 and on November 25, 2019,
we received a timely filed rebuttal brief
from Weldbend Corporation and Boltex
Manufacturing Co., L.P. (collectively,
the petitioners).3 On February 10, 2020,
Commerce extended the final results of
this review to no later than April 14,
2020.4
For a further discussion of events
subsequent to the Preliminary Results,
see the Issues and Decision
Memorandum.5 Commerce conducted
1 See Finished Carbon Steel Flanges From Italy:
Preliminary Results of Antidumping Duty
Administrative Review; 2017–2018, 84 FR 55551
(October 17, 2019) (Preliminary Results), and
accompanying Preliminary Decision Memorandum.
2 See Forgital’s Letter, ‘‘Finished Carbon Steel
Flanges From Italy: Case Brief of Forgital Italy
S.p.A.,’’ dated November 18, 2019.
3 See Petitioners’ Letter, ‘‘Finished Carbon Steel
Flanges from Italy: Rebuttal Brief of Weldbend
Corporation and Boltex Manufacturing Co., L.P,’’
dated November 25, 2019.
4 See Memorandum, ‘‘Finished Carbon Steel
Flanges From Italy: Extension of Deadline for Final
Results of Antidumping Duty Administrative
Review; 2017–2018,’’ dated February 10, 2020.
5 See Memorandum, ‘‘Issues and Decision
Memorandum for the Final Results of the
PO 00000
Frm 00004
Fmt 4703
Sfmt 4703
Analysis of Comments Received
All issues raised in the case and
rebuttal briefs are listed in the appendix
to this notice and addressed in the
Issues and Decision Memorandum. The
Issues and Decision Memorandum is a
public document and is on file
electronically via Enforcement and
Compliance’s Antidumping and
Countervailing Duty Centralized
Electronic Service System (ACCESS).
ACCESS is available to registered users
at https://access.trade.gov. In addition, a
complete version of the Issues and
Decision Memorandum can be accessed
directly at https://
enforcement.trade.gov/frn/.
The signed Issues and Decision
Memorandum and the electronic
version of the Issues and Decision
Memorandum are identical in content.
Application of Adverse Facts Available
For these final results, pursuant to
section 776(a) of the Act, we continue
to rely upon facts otherwise available to
assign estimated weighted-average
dumping margins to the respondents
selected for individual examination in
this review because both Forgital and
ASFO withheld necessary information
that was requested by Commerce,
thereby significantly impeding the
conduct of the review. Further, we
continue to find that both ASFO and
Forgital failed to cooperate by not acting
to the best of their abilities to comply
with requests for information.
Therefore, we continue to apply an
adverse inference in selecting among the
facts available (AFA) to the respondents,
in accordance with section 776(b) of the
Act.
Rate for AFA and Non-Selected
Companies
For these final results, we continue to
assign both Forgital and ASFO the AFA
rate selected in the less-than-fair-value
Administrative Review of the Antidumping Duty
Order on Finished Carbon Steel Flanges From Italy;
2017–2018,’’ dated concurrently with, and hereby
adopted by, this notice (Issues and Decision
Memorandum).
6 See Issues and Decision Memorandum at 2.
E:\FR\FM\20APN1.SGM
20APN1
Agencies
[Federal Register Volume 85, Number 76 (Monday, April 20, 2020)]
[Notices]
[Pages 21824-21825]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-08239]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Bureau of Economic Analysis
Proposed Information Collection; Comment Request; Survey:
Expenditures Incurred by Recipients of Biomedical Research and
Development Awards From the National Institutes of Health (NIH)
AGENCY: Bureau of Economic Analysis, Department of Commerce.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Commerce, as part of its continuing effort
to reduce paperwork and respondent burden as required by the Paperwork
Reduction Act of 1995, invites the general public and other Federal
agencies to comment on continuing information collections related to
the Expenditures Incurred by Recipients of Biomedical Research and
Development Awards survey from the National Institutes of Health (NIH).
DATES: Written comments must be submitted on or before June 19, 2020.
ADDRESSES: Direct all written comments to Jennifer A. Bennett, Chief,
Training and Staff Development Section, Expenditure and Income
Division, Bureau of Economic Analysis, 4600 Silver Hill Road, BE-57,
Washington, DC 20233, or via email at [email protected]. All comments
received are part of the public record. Comments will generally be
posted without change. All Personally Identifiable Information (for
example, name and address) voluntarily submitted by the commenter may
be publicly accessible. Do not submit Confidential Business Information
or otherwise sensitive or protected information. You may submit
attachments to electronic comments in Microsoft Word, Excel, or Adobe
PDF file formats.
FOR FURTHER INFORMATION CONTACT: Requests for additional information or
copies of the information collection instrument and instructions should
be directed to Jennifer A. Bennett, Chief, Training and Staff
Development Section, Expenditure and Income Division (BE-57), Bureau of
Economic Analysis, U.S. Department of Commerce, 4600 Silver Hill Rd.
Washington, DC 20233; or via email at [email protected]ov.
SUPPLEMENTARY INFORMATION:
I. Abstract
The survey obtains the distribution of expenditures incurred by
recipients of biomedical research awards from the National Institutes
of Health (NIH) and will provide information on how the NIH award
amounts are expended across several major categories. This information,
along with wage and price data from other published sources, will be
used to generate the Biomedical Research and Development Price Index
(BRDPI). The Bureau of Economic Analysis (BEA) develops this index for
NIH under a reimbursable contract. The BRDPI is an index of prices paid
for the labor, supplies, equipment, and other inputs required to
perform the biomedical research the NIH supports in its intramural
laboratories and through its awards to extramural organizations. The
BRDPI is a vital tool for planning the NIH research budget and
analyzing future NIH programs. A survey of award recipients is
currently the only means for updating the expenditure category weights
that are used to prepare the BRDPI.
II. Authority
This survey will be voluntary. The authority for NIH to collect
information for the BRDPI is provided in 45 CFR subpart C, Post-Award
Requirements, section 74.21. This sets forth explicit standards for
grantees in establishing and maintaining financial management systems
and records, and section 74.53 which provides for the retention of such
records as well as NIH access to such records.
BEA will administer the survey and analyze the survey results on
behalf of NIH, through an interagency agreement between the two
agencies. The authority for the NIH to contract with the Department of
Commerce (DOC) to make this collection is the Economy Act (31 U.S.C.
1535 and 1536).
The ``Special Studies'' authority, 15 U.S.C. 1525 (first
paragraph), permits DOC to provide, upon the request of any person,
firm, or public or private organization (a) special studies on matters
within the authority of the DOC, including preparing from its records
special compilations, lists, bulletins, or reports, and (b) furnishing
transcripts or copies of its studies, compilations and other records.
NIH's support for this research is consistent with the Agency's duties
and authority under 42 U.S.C. 282.
The information provided by the respondents will be held
confidential and be used for exclusively statistical purposes. This
pledge of confidentiality is made under the Confidential Information
Protection provisions of title V, subtitle A, Public Law 107-347. Title
V is the Confidential Information Protection and Statistical Efficiency
Act of 2002 (CIPSEA). Section 512 (on Limitations on Use and Disclosure
of Data and Information) of the Act, provides that ``data or
information acquired by an agency under a pledge of confidentiality and
for exclusively statistical purposes shall be used by officers,
employees, or agents of the agency exclusively for statistical
purposes. Data or information acquired by an agency under a pledge of
confidentiality for exclusively statistical purposes shall not be
disclosed by an agency in identifiable form, for any use other than an
exclusively statistical purpose, except with the informed consent of
the respondent.''
Responses will be kept confidential and will not be disclosed in
identifiable form to anyone, other than employees or agents of BEA or
agents of NIH, without prior written permission of the person filing
the report. By law, each employee as well as each agent is subject to a
jail term of up to 5 years, a fine of up to $250,000, or both for
disclosing to the public any identifiable information that is reported
about a business or institution.
Section 515 of the Information Quality Guidelines applies to this
survey. The collection and use of this information comply with all
applicable information quality guidelines, i.e., those of the Office of
Management and Budget, Department of Commerce, and BEA.
III. Method of Collection
A survey with a cover letter that includes a brief description of,
and rationale for, the survey will be sent by email to potential
respondents by the first week of August 2020, 2021, and 2022. A report
of the respondent's expenditures of the NIH award amounts, including
NIH awards received as a sub-recipient from another institution,
following the proposed format for expenditure categories included with
the survey form, will be requested to be completed and submitted online
no later than December 8, which in most years will be approximately 120
days
[[Page 21825]]
after mailing. Survey respondents will be selected based on award
levels, which determine the weight of the respondent in the biomedical
research and development price index. Potential respondents will
include (1) The top 100 organizations in total awards, which account
for about 77 percent of total awards; (2) 40 additional organizations
that are not primarily in the ``Research and Development (R&D)
contracts'' category; and (3) 10 additional organizations that are
primarily in the ``R&D contracts'' category.
IV. Data
OMB Control Number: 0608-0069.
Form Number: None.
Type of Review: Regular submission.
Affected Public: Universities or other organizations that are NIH
award recipients.
Estimated Number of Respondents: 150.
Estimated Time per Response: 16 hours but may vary among
respondents because of differences in institution structure, size, and
complexity.
Estimated Total Annual Burden Hours: 2,400 hours.
Estimated Total Annual Cost to Public: $0.
V. Request for Comments
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the NIH, including whether the information has practical utility; (b)
the accuracy of the agency's estimate of the burden (including hours
and cost) of the proposed collection of information; (c) ways to
enhance the quality, utility, and clarity of the information to be
collected; and (d) ways to minimize the burden of the collection of
information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Comments submitted in response to this notice will be summarized
and/or included in the request for OMB approval of this information
collection; they also will become a matter of public record.
Dated: April 14, 2020.
Sheleen Dumas,
Department PRA Clearance Officer, Office of the Chief Information
Officer, Commerce Department.
[FR Doc. 2020-08239 Filed 4-17-20; 8:45 am]
BILLING CODE 3510-EA-P